Hediye Erdjument-Bromage

Dr. Hediye Erdjument-Bromage

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of Biomolecular Techniques : JBT
Verified
Journal Article
Closed access
ECElizabeth Chang
Elizabeth Chang
SPSergei Pourmal
Sergei Pourmal
CZChun Zhou
Chun Zhou
RKRupesh Kumar
Rupesh Kumar
MTMarianna Teplova
Marianna Teplova
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
In recent history, alternative approaches to Edman sequencing have been investigated, and to this end, the Association of Biomolecular Resource Facilities (ABRF) Protein Sequencing Research Group (PSRG) initiated studies in 2014 and 2015, looking into bottom-up ...

23 April 2026 in JCI Insight
Verified
Journal Article
Open access
PDF file
ABAndrew Beenken
Andrew Beenken
TSTian H. Shen
Tian H. Shen
AGAryan Ghotra
Aryan Ghotra
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
JLJeong Lee
Jeong Lee
JBJonathan Barasch
Jonathan Barasch
Donnai-Barrow syndrome (DBS) arises from loss-of-function (LoF) variants in the endocytic receptor low-density lipoprotein receptor–related protein 2 (LRP2; or megalin) and is characterized by low–molecular weight proteinuria and developmental abnormalities. Urinary proteomics of 9 patients with DBS revealed that the urinary proteome of a DBS patient with the missense variant LRP2 p.C1400R was indistinguishable from that of patients with splice site, nonsense, or frameshift mutations. A CRISPR mouse model of the variant was generated to determine the mechanism of LoF and proteinuria. The mutant LRP2 was expressed and observed to dimerize and localize to the proximal tubule apical membrane. However, both fluid-phase and receptor-mediated endocytosis was impaired in the context of a general perturbation of endocytic flux. Immunofluorescence revealed aberrant endocytic recycling with mislocalized RAB11 + and TFR1 + compartments and enlarged lysosomes. Structural modeling showed that the LRP2 assembly likely tolerates the cysteine-to-arginine substitution at the cell surface, but at endosomal pH the variant introduced steric clashes that may disrupt intramolecular interfaces and disturb receptor recycling. These findings point to the importance of LRP2 recycling for global endocytic flux and offer a blueprint for leveraging patient-specific alleles to dissect proximal tubule function.

24 October 2025 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
ARAnna Rodina
Anna Rodina
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
MMMara Monetti
Mara Monetti
ZLZhuoning Li
Zhuoning Li
SCSouparna Chakrabarty
Souparna Chakrabarty
GCGabriela Chiosis
Gabriela Chiosis
Protein-protein interaction (PPI) networks are dynamically remodeled in disease, yet most systems biology approaches focus on changes in protein abundance, overlooking critical interaction-level dysfunction. Here, we present a robust, chemoproteomic method-dysfunctional Protein-Protein Interactome (dfPPI)-that enables high-throughput, systematic, disease-contextual mapping of PPI network dysfunctions in cells and primary human tissue. This method integrates chemical biology probes that selectively capture epichaperome-based interactome assemblies with label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS) and network-based computational analysis, to uncover the rewiring of protein networks not apparent from transcriptomic or proteomic data alone. The dfPPI platform can be applied across disease states, species, and tissues to identify actionable nodes of dysfunction and enable high-resolution, systems-level insights into disease progression. In this protocol, we demonstrate step-by-step procedures for sample preparation, chemical probe treatment, affinity enrichment, label-free LC-MS/MS analysis, and bioinformatics workflows used to generate and interpret dfPPI datasets. This article aims to promote reproducibility and accessibility of this approach, supporting its adoption by the broader systems biology and translational research communities.

29 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMarie E. Sweet
Marie E. Sweet
VDVikas L. Dubey
Vikas L. Dubey
XZXihui Zhang
Xihui Zhang
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
TNThomas Neubert
Thomas Neubert
DSDavid L. Stokes
David L. Stokes
KdpFABC is an ATP-dependent K+pump that ensures bacterial survival in K+-deficient environments. Whereas transcriptional activation of kdpFABC expression is well studied, a mechanism for down regulation when K+levels are restored has not been described. Here we show that KdpFABC is inhibited when cells return to a K+-rich environment. The mechanism of inhibition involves phosphorylation of Ser162 on KdpB, which can be reversed in vitro by treatment with serine phosphatase. Mutating Ser162 to Alanine produces constitutive activity, whereas the phosphomimetic Ser162Asp mutation inactivates the pump. Analyses of the transport cycle show that serine phosphorylation uncouples the pump and blocks the cycle after formation of the catalytic aspartyl phosphate intermediate (E1∼P). Molecular dynamics simulations show that serine phosphorylation has allosteric effects that potentially explain the uncoupling. This regulatory mechanism, unique amongst P-type pumps, furthers our understanding of how bacteria control potassium homeostasis to maintain cell volume and osmotic potential.

24 October 2025
Verified
Dataset
Closed access
PDF file
ARAnna Rodina
Anna Rodina
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
MMMara Monetti
Mara Monetti
ZLZhuoning Li
Zhuoning Li
SCSouparna Chakrabarty
Souparna Chakrabarty
GCGabriela Chiosis
Gabriela Chiosis
Protein-protein interaction (PPI) networks are dynamically remodeled in disease, yet most systems biology approaches focus on changes in protein abundance, overlooking critical interaction-level dysfunction. Here, we present a robust, chemoproteomic method-dysfunctional Protein-Protein Interactome (dfPPI)-that enables high-throughput, systematic, disease-contextual mapping of PPI network dysfunctions in cells and primary human tissue. This method integrates chemical biology probes that selectively capture epichaperome-based interactome assemblies with label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS) and network-based computational analysis, to uncover the rewiring of protein networks not apparent from transcriptomic or proteomic data alone. The dfPPI platform can be applied across disease states, species, and tissues to identify actionable nodes of dysfunction and enable high-resolution, systems-level insights into disease progression. In this protocol, we demonstrate step-by-step procedures for sample preparation, chemical probe treatment, affinity enrichment, label-free LC-MS/MS analysis, and bioinformatics workflows used to generate and interpret dfPPI datasets. This article aims to promote reproducibility and accessibility of this approach, supporting its adoption by the broader systems biology and translational research communities.

11 September 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
MVMaria Luisa Valle
Maria Luisa Valle
CJChristopher Lawrence Carlos De Jesus
Christopher Lawrence Carlos De Jesus
BGBitseat Getaneh
Bitseat Getaneh
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
JLJames Loveland
James Loveland
JGJorge Ghiso
Jorge Ghiso
Hyperhomocysteinemia (HHcy), a risk factor for cardiovascular, neurodegenerative, and metabolic dysfunctions in humans, has been recapitulated in murine models by genetic and dietary modifications. The relevance of HHcy in clinical and experimental settings has led to the development of various analytical techniques with varying sensitivity and sample volume requirements. This study uses a fit-for-purpose, small-volume LC-MS/MS workflow to quantify plasma homocysteine (Hcy), methionine (Met), and cysteine (Cys) in a diet-induced HHcy mouse model. Using these assays that overcome limitations imposed by sample availability in small animals, our study evaluated circulating levels of these amino acids in C57BL/6 mice fed a HHcy-inducing diet rich in Met and lacking vitamins B6, B9, and B12. The increased Hcy and decreased Cys plasma concentrations observed in these mice correlated with decreased glutathione concentrations in brain homogenates and concomitant increase in the activity of the antioxidant enzyme Glutathione-S-Transferase and in the levels of the lipid peroxidation marker malondialdehyde. Overall, our work links plasma HHcy to the induction of brain oxidative stress, supporting the role of dietary modifications as complementary therapeutic strategies for neurodegenerative conditions.